CITIC (00267): CITIC Pacific Special Steel Group (000708.SZ) reported a net profit attributable to shareholders of approximately RMB 4.16 billion for the first three quarters, a year-on-year decrease of 3.94%.
CITIC (00267) announced the first three quarters of 2026 results for CITIC Pacific Special Steel Group (000708.SZ): operating revenue of approximately RMB 80.706 billion, a year-on-year decrease of 0.62%; net profit attributable to shareholders of the listed company of approximately RMB 4.16 billion, a year-on-year decrease of 3.94%; basic earnings per share of RMB 0.824.
CITIC (00267) announced the first three quarters of 2026 results for CITIC Pacific Special Steel Group (000708.SZ), with operating revenue of approximately RMB 80.706 billion, a year-on-year decrease of 0.62%; net profit attributable to shareholders of the listed company of approximately RMB 4.16 billion, a year-on-year decrease of 3.94%; and basic earnings per share of RMB 0.824.
Related Articles
ZHONGYU ENERGY (03633) repurchased 400,000 shares for HK$1.0791 million on October 22.
Jiangsu Hengrui Pharmaceuticals (01276) repurchased 150,000 A shares on October 22 for approximately RMB 6.9152 million.
Jiangsu Hengrui Pharmaceuticals(600276.SH): Rivilutamide Tablets Receives Drug Clinical Trial Approval Notice
ZHONGYU ENERGY (03633) repurchased 400,000 shares for HK$1.0791 million on October 22.
Jiangsu Hengrui Pharmaceuticals (01276) repurchased 150,000 A shares on October 22 for approximately RMB 6.9152 million.
Jiangsu Hengrui Pharmaceuticals(600276.SH): Rivilutamide Tablets Receives Drug Clinical Trial Approval Notice
